Can we use imipenem and meropenem Vitek 2 MICs for detection of suspected KPC and other-carbapenemase producers among species of Enterobacteriaceae?

Journal of Clinical Microbiology

Volumn 49, Issue 2, 2011, Pages 697-701

  Pasteran, Fernando ^a   Lucero, Celeste ^a   Soloaga, Rolando ^b   Rapoport, Melina ^a   Corso, Alejandra ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

^b Hospital Naval Cirujano Mayor Dr Pedro Mallo   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEMASE; IMIPENEM; MEROPENEM;

ALGORITHM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; LABORATORY AUTOMATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; ENTEROBACTERIACEAE; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; SENSITIVITY AND SPECIFICITY; THIENAMYCINS;

ENTEROBACTERIACEAE;

EID: 79951497186     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01178-10     Document Type: Article

References (30)

1. Anderson, K., et al. 2007. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J. Clin. Microbiol. 45:2723-2725.
2. Boyd, N. K., et al. 2009. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., abstr. D-731/192.
3. Bratu, S., et al. 2005. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimicrob. Agents Chemother. 49:3018-3020.
4. Bulik, C., et al. 2010. Comparison of meropenem MICs and susceptibility for carbapenemase-producing Klebsiella pneumoniae by various testing methods. J. Clin. Microbiol. 48:2402-2406.
5. Bush, K., and G. Jacoby. 2010. Updated functional classification of betalactamases. Antimicrob. Agents Chemother. 54:969-976.
6. Carmeli, Y., et al. 2010. Controlling the spread of carbapenemase- producing Gram-negatives: therapeutic approach and infection control. Clin. Microbiol. Infect. 16:102-111.
7. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: 20th informational supplement. CLSI publication M100-S20. Clinical and Laboratory Standard Institute, Wayne, PA.
8. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement (June 2010 update). CLSI publication M100-S20-U. Clinical and Laboratory Standards Institute, Wayne, PA.
9. Doumith, M., M. J. Ellington, D. M. Livermore, and N. Woodford. 2009. Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK. J. Antimicrob. Chemother. 63:659-667.
10. Girlich, D., L. Poirel, and P. Nordmann. 2008. Do CTX-M beta-lactamases hydrolyse ertapenem? J. Antimicrob. Chemother. 62:1155-1156.
11. Girlich, D., L. Poirel, and P. Nordmann. 2009. CTX-M expression and selection of ertapenem resistance in Klebsiella pneumoniae and Escherichia coli. Antimicrob. Agents Chemother. 53:832-834.
12. Giske, C., L. Gezelius, Ø. Samuelsen, M. Warner, A. Sundsfjord, and N. Woodford. 2010. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin. Microbiol. Infect. [Epub ahead of print.] doi: 10.1111/j.1469-0691.2010.03294.
13. Gomez, S., et al. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C2-1157.
14. Johnson, J. R., B. Johnston, C. Clabots, M. Kuskowski, and M. Castanheira. 2010. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin. Infect. Dis. 51:286-294.
15. Lartigue, M. F., L. Poirel, C. Poyart, H. Réglier-Poupet, and P. Nordmann. 2007. Ertapenem resistance of Escherichia coli. Emerg. Infect. Dis. 13:315-317.
16. Leavitt, A., et al. 2009. Ertapenem resistance among extended-spectrum- beta-lactamase-producing Klebsiella pneumoniae isolates. J. Clin. Microbiol. 47:969-974.
17. McGettigan, S., K. Andreacchio, and P. Edelstein. 2009. Specificity of ertapenem susceptibility screening for detection of Klebsiella pneumoniae carbapenemases. J. Clin. Microbiol. 47:785-786.
18. Miriagou, V., et al. 2010. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin. Microbiol. Infect. 16:112-122.
19. Nordmann, P., G. Cuzon, and T. Naas. 2009. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect. Dis. 9:228-236.
20. Oteo, J., M. Pérez-Vázquez, and J. Campos. 2010. Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impact. Curr. Opin. Infect. Dis. 23:320-326.
21. Pasteran, F., T. Mendez, L. Guerriero, M. Rapoport, and A. Corso. 2009. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J. Clin. Microbiol. 47:1631-1639.
22. Pasteran, F., T. Mendez, L. Guerriero, M. Rapoport, and A. Corso. 2010. Controlling false-positive results obtained with the Hodge and Masuda assays for detection of class A carbapenemase in species of enterobacteriaceae by incorporating boronic acid. J. Clin. Microbiol. 48:1323-1332.
23. Pasteran, F. 2010. Abstr. 14th Int. Cong. Infect. Dis., abstr. 1964.
24. Pitout, J. D. 2010. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333.
25. Poirel, L., et al. 2010. Abstr. 50th Intersci. Conf. Antimicrob. Agents Chemother., abstr. C1-675.
26. Tenover, F., et al. 2006. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg. Infect. Dis. 12:1209-1213.
27. Walther-Rasmussen, J., and N. Høiby. 2006. OXA-type carbapenemases. J. Antimicrob. Chemother. 57:373-383.
28. Wang, X. D., J. Cai, H. Zhou, R. Zhang, and G. Chen. 2009. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency. J. Med. Microbiol. 58:1196-1202.
29. Woodford, N., et al. 2010. Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae. J. Clin. Microbiol. 48:2999-3002.
30. Woodford, N., et al. 2007. Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory. Int. J. Antimicrob. Agents 29:456-459.